Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus
Written by Jessica Mitacek on May 8, 2026
Key Points
Following a settled legal dispute with Novo Nordisk, HIMS has transitioned from selling compounded weight-loss drugs to offering brand-name Wegovy and Ozempic.
While the deal was finalized in March, investors are eager to see if this pivot will boost the top line or if the financial impact likely won’t be seen until Q2.
Despite its recent rally, the stock remains highly volatile with short interest exceeding 35%.
Healthcare stocks have struggled in 2026. With a year-to-date (YTD) loss of about 6%, that corner of the market has been the worst performer among all 11 sectors of the S&P 500 in 2026.
While that has been reflected in the YTD losses of some of Big Pharma’s biggest names, it has also adversely affected mid-cap stocks like telehealth platform Hims & Hers Health (NYSE: HIMS), which has fallen by more than 23% in 2026.
One day after a big announcement from the U.S. Food & Drug Administration (FDA) caused shares of HIMS to jump by nearly 4%, the stock gave it all back on Thursday, falling by nearly 5% as traders locked in profits.
But that wasn’t enough to derail the stock’s recent rally, which has seen HIMS gain nearly 32% over the past month and around 77% since its 52-week low on Feb. 27. As the company prepares to report Q1 2026 earnings on May 11, here’s what investors should watch for.
Is the Novo Nordisk Partnership Already Paying Off?
Following a well-publicized legal disputeearlier this year with Denmark-based Novo Nordisk (NYSE: NVO)—the eighth largest publicly traded pharmaceutical company in the world with a market cap of more than $204 billion—it’s been smooth sailing for Hims & Hers.
Since Novo Nordisk dropped its patent infringement lawsuit on March 9, HIMS has been on a tear. Not only did the Danish firm abandon its case, but it also reached a deal that allows Hims & Hers to sell Novo Nordisk’s brand-name Wegovy and Ozempic through its direct-to-consumer and virtual medical services platform.
As part of that deal, Hims & Hers agreed to stop advertising its compounded GLP-1 products, which given the FDA’s announcement that it is proposing that semaglutide, tirzepatide, and liraglutide be excluded from its 503B bulks list, could prove prescient for the company.
Wall Street will be looking for how that deal has impacted Hims & Hers’ top line. Despite the strategic shift being announced on March 9, Novo Nordisk’s GLP-1 products were not available for sale through the online platform until March 26. The books for Q1 closed on March 31, so those gross sales may not materialize on Hims & Hers’ income statement until Q2.
Will Hims & Hers Continue to Show Subscriber Growth?
The market will also be looking for confirmation that Hims & Hers’ total subscribers are holding above 2.5 million, if not steadily growing from there. That benchmark was reached near the end of 2025 and marked a more than 16% increase from the 2.2 million subscribers the company had at the end of 2024.
That growth is proving to be sustainable, after Hims & Hers ended 2023 with 1.5 million. But more important than the raw subscriber count is how the telehealth company generates 90% of its recurring revenue from its customer base.
Approximately 82% of its users remain on the platform for more than three months, and if Hims & Hers can demonstrate that it is sustainable, it should bolster full-year guidance.
Meanwhile, analysts are expecting earnings per share (EPS) of around three to four cents, which would mark an estimated 90% year-over-year decline. That may already be priced in, given the stock’s YTD performance, but a miss could accelerate selling.
The same goes for quarterly revenue, which consensus forecasts put in the range of $616 million to $619 million. Wall Street is already bracing for a “reset quarter” after revenue growth tapered from nearly 111% in Q1 2025 to less than 29% in Q4, so any surprise to the upside could spur another leg to the current rally.
When the SpaceX IPO launches, most retail investors will be locked out. The banks, funds, and insiders get in early – while everyone else waits on the sidelines.
But one small infrastructure supplier – a critical piece Musk can’t scale the Colossus network without – is still trading well under institutional radar. A new briefing reveals the name and ticker at no cost.Get the SpaceX infrastructure stock name and ticker here
Analysts Are Taking a Wait-and-See Approach
Despite an average 12-month price target of nearly $32, which implies potential upside of around 24%, Wall Street remains tepid on the stock.
Of the 17 analysts currently covering HIMS, four assign it a Buy rating, 12 assign it a Hold rating, and just one assigns it a Sell rating. Overall, the stock receives a consensus Hold rating.
Institutional ownership of nearly 64% falls within the typical range for mid-cap companies. Outflows of $1.62 billion have nearly caught up to inflows of $1.8 billion over the past 12 months after selling accelerated in Q4 2025. But that trend reversed in Q1, with institutional selling 88% lower than institutional buying.
With a high beta of 2.43, the inherently volatile stock is currently being heavily targeted by bears. Concerningly, more than 35% of the float—or nearly 70 million shares of the almost 228 million shares outstanding—is currently shorted.
Still, strong earnings could shift sentiment and propel the stock closer to the consensus analyst price target. Shareholders and prospective investors should mark their calendars for Monday, May 11, when Hims & Hers Health reports Q1 2026 results.
In the summer of 1961, a young American psychologist began an experiment on obedience. Not yet 30, he’d recently earned his Ph.D. in psychology from Harvard under the tutelage of Gordon Allport, and he wanted to understand how ordinary people could participate in atrocities.
Do you have feedback for our coverage? Tell us what you think by replying to this email.
We are still running special subscription deals in light of the ongoing war with Iran. Take this opportunity to become an Epoch Times subscriber—at the best rates possible—while they’re still available!
The Epoch Times strives to fill the void at a time when partisan and biased reporting has become commonplace. As staunch believers in traditional journalism, we rigorously pursue facts and accuracy, leaving views strictly as opinions.
When you do choose to explore people’s perspectives, we guarantee you the freedom of thought. Too often, certain voices are suppressed or silenced—that’s never the case at The Epoch Times. Browsing through the commentaries, you will immediately recognize honest, refreshing, and at times courageous discussions on topics perhaps purposefully left out by others: HollywoodCan Still Make Great Movies; What I Sawat the White House Correspondents’ Dinner; A Former Anthropic Employee’s Last Warning
… They are truly a feast for the mind.
Explore our entire treasure trove of content for $0.50 per week for a full year—our best annual plan. Subscribe Now
🎨 Fine Arts: A mother’s embrace — capturing pure and unconditional love: Over generations, five classical paintings demonstrate the timeless subject of maternal love.
🎼 Music:Stephen Foster, the father of American music: It’s only fitting that the man who would define the United States’s musical scene was born on our nation’s 50th birthday—July 4, 1826, in Lawrenceville, Pennsylvania, a town near Pittsburgh.
📜 American Essence: Panic, innovation, and the building of America’s first world’s fair: During the country’s 90th year, John Campbell, a professor at Wabash College in Indiana, became the first to officially propose the idea of hosting a world’s fair commemorating 1776.
From the Ground Up:250 Years: Old North Church Is the Living Story of America: Best known for its role in the American Revolution, the Christ Church of Boston’s North End neighborhood is still home to a thriving Episcopal congregation. Read more →
FOLLOW US * When sharing an article, giftaccess@TheEpochTimes.com is added to the list of recipients. If your friend is not already a subscriber, we will send them a special link for free access to the article.
Manage your email preferences here or unsubscribe from Bright here.
Today we received miraculous news from Brophy teacher Mike Welty ’83 regarding his daughter Mary Welty (XCP ’12). After suffering a serious medical emergency earlier this week, Mary is currently awake and showing strong signs of recovery. Please continue to keep Mary and her family in your prayers, they are grateful for the support and love of the Brophy and Xavier communities.
A landmark Cooperative Research and Development Agreement (CRADA) with the U.S. Navy has served as the ultimate institutional validation for Odysight.ai (NASDAQ: ODYS), sending shares into a volatile, high-volume surge.
The deal centers on deploying Odysight.ai’s advanced visual sensing and artificial intelligence (AI) platform for condition-based maintenance on mission-critical aircraft carrier arresting cables.
While the market initially reacted to the headline, the core investment thesis appears to be anchored by a much deeper fundamental story: a rapidly monetizing $13.8 million backlog and a pristine, zero-debt balance sheet. As global defense budgets aggressively pivot toward predictive maintenance and operational readiness, this de-risked micro-cap may offer an asymmetrical entry point before its technology scales fleet-wide.
Why This CRADA Is a Game-Changer
The CRADA with the Naval Air Warfare Center Aircraft Division Lakehurst (NAWCAD) is much more than a run-of-the-mill supply contract. For a micro-cap like Odysight.ai, it represents a deep, formal collaboration that embeds its technology at the heart of the Pentagon’s modernization efforts. This partnership provides invaluable, real-world operational feedback, allowing Odysight.ai to refine its algorithms and hardware in one of the world’s most demanding environments.
This direct line to the end-user significantly de-risks future product development and provides a powerful competitive moat. Successfully proving the technology on carrier arresting cables, a system under immense and constant operational stress, is a strategic masterstroke.
It provides Odysight.ai with an unimpeachable case study to leverage for expansion into other mission-critical systems. This validation establishes a clear, logical pathway for scaling across the U.S. Navy’s fixed-wing aircraft, rotary-wing helicopters, and ground vehicle fleets. This approach mirrors a successful pattern of securing contracts with elite military operators worldwide. Odysight.ai has already logged key operational milestones with the Israeli Air Force for its SH-60 helicopter program and the Italian Air Force for AW139 platform testing. These engagements cement the system’s interoperability and establish Odysight.aias a trusted partner within premier international defense supply chains, not just a vendor.
Why Zero Debt and a $13.8M Backlog Matter
Many pre-profitability technology sector companies are hamstrung by weak balance sheets and the constant threat of dilutive financing. Odysight.aistands in stark contrast to this narrative. The technology developer exited its 2025 fiscal year with approximately $26 million in cash and equivalents and, critically, zero long-term debt. This robust liquidity profile is a powerful strategic asset. It provides a multi-year operational runway, granting management the flexibility to execute its pilot programs and scale production without the immediate pressure to tap equity markets. This financial independence allows Odysight.ai to negotiate from a position of strength and focus entirely on technological and commercial execution.
This financial stability is supercharged by exceptional revenue visibility. Odysight.aiis currently working through a contracted backlog of $13.8 million. This figure, representing more than 4.5 times Odysight.ai’s trailing 12-month revenue, signals a fundamental inflection point. Odysight.ai is transitioning from a speculative research-and-development entity into a commercial-stage enterprise with a clear path to accelerated growth. The successful monetization of this backlog throughout 2026 will be the key performance indicator for investors. Consistent conversion of this backlog to top-line revenue could trigger a significant re-rating of the stock, as the market shifts from valuing potential to rewarding proven execution.
The Market’s Volatile Reaction
The Navy CRADA announcement on May 11, 2026, served as a powerful market catalyst, igniting a trading firestorm. Shares of Odysight.ai saw volume surge to 39.12 million, an increase from its daily average of just under 470,000. This surge propelled the stock to an intraday high of $11.30 before aggressive profit-taking sent it to $4.75 by the closing bell.
This extreme price action, which triggered a Limit Up-Limit Down (LULD) trading pause, confirms that both retail momentum traders and institutional algorithms have now firmly fixed their sights on the equity. While the sharp retracement highlights near-term volatility, the record volume and elevated close signal a permanent shift in market awareness.
Aiding this newfound market interest is a shrewd strategic move to enhance liquidity and broaden the shareholder base. On April 9, 2026, Odysight.aifinalized a dual listing on the Tel Aviv Stock Exchange (TASE). This provides direct access to a deep pool of sophisticated regional institutional capital. This investor base has a nuanced understanding of the defense technology sector and is well-positioned to appreciate the long-term value of Odysight.ai’s contractual milestones, potentially creating a more stable valuation floor for the stock moving forward.
From Pilot to Profit: What to Watch for Next
The path forward for Odysight.ai hinges on execution. While the current analyst consensus rating is a Hold, this is common for a company at its commercial inflection point. The recent Moderate Buy rating and $10 price target from Benchmark Co. suggest that some on Wall Street are beginning to price in the successful execution of the current backlog and the immense scalability of the Navy partnership. The key metric for investors to monitor will be the rate at which the $13.8 million backlog is converted into recognized revenue in the coming quarterly reports. A consistent, sequential increase will validate the entire commercial model.
Furthermore, any announcements of follow-on contracts stemming from the NAWCAD pilot program would serve as a powerful upside catalyst, confirming the land-and-expand strategy. While Odysight.ai appears financially well-positioned to withstand near-term headwinds, investors should remain cognizant of the inherent risks of any micro-cap investment, including customer concentration and the operational challenges of scaling production to meet enterprise-level demand. For investors with a higher risk tolerance and a focus on disruptive defense technology, Odysight.ai offers a de-risked ground-floor opportunity. More conservative market participants may prefer to see a few quarters of consistent backlog conversion before committing capital. READ THIS STORY ONLINE
Banzai International (NASDAQ: BNZI) posted full-year 2025 revenue of $12.2 million, up 169% year-over-year, with Q4 growth of 116% and gross margins expanding to 81.9% – signaling a high-efficiency SaaS model gaining traction.
With over 150,000 customers, a planned acquisition of ConnectAndSell expected to add roughly $15 million in annual revenue, and a recent Zacks Rank No. 2 Buy upgrade, institutional confidence in BNZI’s improving fundamentals is building. Technical indicators also suggest a potential bottom formation.SEE WHY ANALYSTS ARE WARMING UP TO THIS AI MARTECH TURNAROUND PLAY
When an aerospace upstart’s next-generation BlueBird satellites are the largest commercial communication arrays to ever be deployed in low Earth orbit (LEO), expectations for that company can be astronomical.
So when space-based cellular broadband network provider AST SpaceMobile (NASDAQ: ASTS) reported Q1 2026 results on Monday, May 11, investors were understandably deflated by a bearish double-miss.
In the lead-up to the earnings call, which was held after the bell, ASTS gained nearly 6%. But after announcing dramatic misses on earnings and revenue, the stock sold off during after-hours trading as the market’s palpable disappointment resulted in a loss of more than 13%.
Here’s what investors need to know about the SpaceX rival going forward.
AST SpaceMobile’s Q1 Disappointment Brings Investors Back Down to Earth
Despite the company’s promising backdrop, the space-based cellular provider posted Q1 earnings per share(EPS) of negative 66 cents versus analyst expectations of negative 23 cents.
The EPS miss was AST SpaceMobile’s fifth in as many quarters.
Quarterly revenue also disappointed, with $14.74 million missing the consensus mark of $39.01 million by a country mile. That was particularly magnified when looking at the company’s Q4 2025 revenue of $54.31 against expectations for $39.53 million.
Fortunately, the Q1 report wasn’t without its highlights. AST SpaceMobile reported a healthy balance sheet with approximately $3.5 billion in cash, cash equivalents, and restricted cash as of March 31.
The company is still in its nascent stages of revenue generation, but it should be able to continue seamlessly scaling thanks to more than half a million square feet of manufacturing and operations space around the globe. BlueBird 8, 9, and 10 are expected to be delivered within a month, and AST SpaceMobile is in the process of assembly through BlueBird 33. Ultimately, the firm plans to have 100 BlueBird satellites in its fleet.
In his earnings call comments, CEO Abel Avellan highlighted the company’s 95% vertically integrated manufacturing strategy, noting how it provides a long-term advantage with its manufacturing team ramping up significantly over the past several quarters.
AST SpaceMobile’s Volatility Should Be Expected
AST SpaceMobile has dealt with its fair share of setbacks this year. Launch delays and Blue Origin deployment mishaps have resulted in heightened volatility in share prices. As a result, ASTS now carries a beta of 2.60, meaning it is more than two and a half times as volatile as the broad market.
But with high betas come high risk-reward opportunities. Shortly after the BlueBird 7 LEO failure in late April, the stock bounced back within a week on news that the U.S. Federal Communications Commission granted AST SpaceMobile commercial authority to deliver direct-to-device, or D2D, cellular broadband connectivity from outer space nationwide in the United States.
According to a company press release, AST SpaceMobile entered into an agreement with the United States Space Development Agency for the Europa Track 2 Commercial Solutions program as part of “the Hybrid Acquisition for proliferated Low-Earth Orbit (HALO) program,” which carries a total contract value of approximately $30 million.
So selloffs are nothing new to shareholders, many of whom have endured the highs and lows of buying and holding ASTS. Over the past year, while compiling a gain of nearly 204%, the stock has seen trough-to-peak gains as high as 315% while enduring at least 15 double-digit pullbacks.
After a Big Earnings Miss, ASTS Receives a Mixed Outlook
The silver lining is that the company’s revenue is expected to continue growing, which should result in earnings nearly breaking even over the next year. Based on a trailing 12-month EPS of negative $1.32, AST SpaceMobile’s earnings are expected to grow from negative 99 cents to negative one cent over the next four quarters.
Nonetheless, analysts are now understandably conservative in their expectations. The stock’s average 12-month price target is $82.51, indicating a potential upside of over 15%. Meanwhile, AST SpaceMobile has a consensus Reduce rating based on the 10 analysts who currently cover it.
Short interest of nearly 18%—or nearly 54 million shares of the 382 million shares outstanding—remains a short-term concern. However, long-term, the smart money appears to remain bullish on ASTS. Over the past 12 months, institutional buyers have injected nearly $3 billion into the stock, while outflows have totaled less than $500 million. READ THIS STORY ONLINE
Mode Mobile – the company turning smartphones into EarnPhones – has posted $115M+ in revenue, 3-year growth of 32,481%, and an ecosystem of 490M+ users. With a Nasdaq ticker ($MODE) secured and Kevin Harrington of Shark Tank among early backers, the company is positioning for a potential IPO.
After getting beaten down for the better part of a year, Axon Enterprise (NASDAQ: AXON) scored a big win after its last earnings report. Shares surged by nearly 11% following the firm’s May release, with the company posting impressive sales, earnings, and guidance.
Nonetheless, the defense stock is down big time, still trading at less than 50% of its 52-week high reached in August 2025. Some of this fall was likely justified, but other aspects are much more questionable.
At past highs, Axon traded at a forward price-to-earnings ratio (P/E) near 130x; evident of a company “priced for perfection.”
However, the stock has also sunk amid fears of artificial intelligence in the software industry. This comes even though hardware sales play a critical role in Axon’s business and make its flywheel effect work.
When push comes to shove, Axon’s results show why there is a lot of room for optimism around this name going forward.
Axon’s Beat and Raise Q1
In Q1 2026, Axon reported revenue of $807.3 million, good for a growth rate of 34% year over year (YOY). This very handily beat estimates of $778.9 million. Meanwhile, adjusted earnings per share (EPS) rose by just under 10% to $1.61, a slight beat over expectations of $1.60. Notably, gross margins took a meaningful hit, leading to revenue growing much faster than adjusted EPS.
Gross margin fell by 150 basis points YOY to 59.1%, with the company noting global tariffs as the primary driver. This is another legitimate factor hurting Axon stock, being a persistent talking point on earnings calls.
Despite this, the company maintained its full-year adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) margin guidance of 25.5%. Axon also raised its full-year revenue growth guidance to a midpoint of 31%. This is a meaningful boost over past midpoint guidance of 29%, coming as contracted booking growth increased 44% YOY, well above Q1 sales growth. Importantly, Axon is seeing considerable growth from its AI offerings, counteracting the narrative that the technology is a large threat to Axon rather than a tailwind.
AI Growth Soars as Law Enforcement Buys In
Axon’s AI Era plan is its most expensive hardware and software package for law enforcement. Here, bookings rose by 140% YOY, with the company noting that “nearly all large domestic law enforcement agencies are now including AI in their purchases.” That’s a very strong statement, showing that AI is moving to the core of how agencies make purchasing decisions, rather than being a nice-to-have.
Slide 23 of the company’s Investor Deck also illustrates how hardware sales form the basis of the company’s software, services, and AI flywheel effect. In year one of the AI Era Plan, hardware sales represent about half of revenue. This is where the company sells products like tasers, body cameras, virtual reality headsets, and drones.
However, after year one, hardware sales are very minimal. Over a five-year period, the combination of AI and non-AI software and services makes up over 75% of total plan revenue. This includes offerings like Draft One, where AI uses body camera recordings to create a first draft of incident reports, saving officers time on paperwork.
Agencies continue to pay for these services over several years, but they are useful only after first purchasing the necessary hardware. So, while Axon certainly has significant software exposure, its hardware-first model provides protection from AI competition that software-only companies do not possess.
Adding to this is the fact that demand for Axon’s drones is spiking. During the quarter, its counter-drone revenue increased by 300% YOY. Bookings rose considerably more, up 500% YOY, indicating that demand is accelerating.
Axon Continues Its Post-Earnings Success; Markets Remain Unconvinced
Notably, despite recent drops, Axon has continually shown the strength of its business through financial results. Following its past 10 earnings releases, Axon has seen an average post-earnings gain of approximately 12%. That is a feat investors would be hard-pressed to find in many other stocks.
Surely, past post-earnings success does not mean it will continue. However, it is evidence of one thing: the market has repeatedly underestimated Axon and then corrected after the company provides numbers that it cannot deny. It’s arguable that the same thing is happening now, given the stock’s massive decline and post-earnings jump.
Furthermore, much of Axon’s price action continues to coincide with the price action of the overall software market. This indicates that investors have yet to separate Axon from software stocks, despite the significant differences in its business model.
Analysts continue to have a positive outlook on Axon. The MarketBeat consensus price target sits near $713, implying upside north of 75%. Targets updated after the company’s earnings report are considerably lower, averaging around $604. However, this figure still implies substantial upside of just over 50%. READ THIS STORY ONLINE
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White – reaching millions of combat sports and biohacking followers worldwide.
On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides – and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.READ THE FULL REPORT ON THIS SMALL-CAP PEPTIDE COMPANY NOW
The Night Owl is a financial newsletter that provides in-depth market analysis on stocks of interest to individual investors. Published by MarketBeat and Early Bird Publishing, The Night Owl is delivered around 9:00 PM Eastern Sunday through Thursday. If you give a hoot about the market, The Night Owl is the newsletter for you.
I will be calling you on Thursday, May 14th, because I need to update you on an urgent humanitarian crisis that is unfolding in Israel.
Please do everything you can to be part of this call.
I will call you on the number that we have on file, but you can also join the live call by using the number provided below.
Date: Thursday, May 14th Time: 8:00 PM Eastern Time – (That’s 5:00 PM Pacific Time) Phone: 844.881.1315
You will only be able to connect to this live event by calling this number while the call is still in progress. The call is expected to last 15 minutes or less.
Thank you for being a vital part of this worldwide prayer movement!Your ambassador to Jerusalem,
THE YEAR’S BIGGEST MOMENTS IN SPORTSFrom the high-speed intensity of NASCAR and INDYCAR to the game-changing plays of MLB and the NFL, plus every match of FIFA World Cup 2026™—stream the action LIVE.
Start Streaming ICONIC LEAGUES. UNRIVALED ACCESS.Stream the NASCAR Cup Series, NTT INDYCAR Series, LIV Golf, MLS, MLB, the UFL, FIFA World Cup 2026™, College Football, College Basketball, the NFL and the World Series LIVE. STORIES BEYOND THE GAMEExplore the triumphs, heartbreaks and turning points that shaped sports history. These are the stories fans never forget.
Start Streaming AVAILABLE WHERE YOU WATCH DOWNLOAD THE FOX ONE MOBILE APP Follow Us:
Do you have a question? Click here to visit our Help Center. Please do not reply to this message.
Love New Times? Thanks to a recent Google update, you can now select us as a preferred source to see our stories first in search results. Thank you in advance for your ongoing support of local journalism.
Catholic “AI for good.” Instant answers and guidance to any question or problem. Try free for 7 days.
A Night Prayer
Jesus Christ, my God, I adore You and thank You for all the graces You have given me this day. I offer You my sleep and all the moments of this night. I place myself and all my loved ones, wherever they may be, in Your sacred side and under the mantle of Our Blessed Mother. Let Your holy angels stand watch and keep us in peace. Amen.
Quote of the Day
“Can anyone receive Jesus into his heart and not die?” -Bl. Imelda Lambertini
Today’s Meditation
“Beginners must realize that in order to give delight to the Lord they are starting to cultivate a garden on very barren soil, full of abominable weeds. His Majesty pulls up the weeds and plants good seed. Now let us keep in mind that all of this is already done by the time a soul is determined to practice prayer and has begun to make use of it. And with the help of God we must strive like good gardeners to get these plants to grow and take pains to water them so that they don’t wither but come to bud and flower and give forth a most pleasant fragrance to provide refreshment for this Lord of ours.” —St. Teresa of Avila, p. 52
What if your AI didn’t spy on you — and actually aligned with your faith?
With over 250,000 downloads, Truthly is the Catholic AI app built to help you navigate the internet faithfully. Ask anything. Get answers you can trust — grounded in truth, not trends.
The daily examination of conscience is an ancient Catholic practice. It’s very simple, and it’s designed to help us identify our sins and weaknesses so that we can improve and grow stronger in the spiritual life, while providing an excellent ongoing preparation for regular Confession. It consists of taking a few minutes at the end of the day to prayerfully review our actions in the light of God’s commandments, followed by the Act of Contrition.
Reflect on the victories and losses
Actively reflecting on the high and low points of the day can help you live more intentionally and bring a renewed sense of resolve into the following day.
Review your actions, words, and thoughts today. Did you actively guard yourself against temptation? Where did sin creep in?
In what moments did you practice virtue and moral courage?
Were you attuned to the Holy Spirit’s promptings today? Where did you feel His inspiration?
Ask Him for the graces necessary to follow His Will more purposefully tomorrow.
Act of Contrition
O my God, I am heartily sorry for having offended Thee, and I detest all my sins because of Thy just punishments, but most of all because they offend Thee, my God, Who art all good and deserving of all my love. I firmly resolve with the help of Thy grace to sin no more and to avoid the near occasions of sin. Amen.
Practice gratitude
It is God’s love that has brought you into existence and to this exact moment. Practice looking for His hand in your day.
Where did you feel His loving gaze upon you today?
What people or moments helped you see God in your life?
Thank God for all these moments!
Ask Him to help you recognize His blessings and providence tomorrow.
Renew your commitment to Christ
Remember: our Faith is founded upon a Person—Christ! Renew your personal love and devotion to Him.
Thank God for the gift of His Son Jesus and our call to be His disciples.
Tell the Lord of your desire to know Christ more personally.
If possible, set an intention for your day tomorrow. Ask Our Lord to guide you in this act.
Pray a Hail Mary, Our Father, or another beloved prayer.
Rest with God
The Mighty One, God the Lord, speaks and summons the earth from the rising of the sun to its setting. — Psalm 50:1
Human to human cases and deaths are now being reported…
And this is eerily similar to a pandemic warning RFK Jr. gave years ago.
If you born on or before January 1st of 1966, then you need to see THIS now.
P.S. Liberals called him a conspiracy theorist but it now turns out that RFK Jr. was RIGHT. See his life-saving warning for all US seniors by clicking here now.
This ad is sent on behalf of NewMarket Health Publishing, LLC. P.O. Box 913, Frederick, MD 21705, USA.
This email is never sent unsolicited. You have received this Newsmax email because you subscribed to it or someone forwarded it to you. To opt out, see the links below.
Remove your email address from our list or modifyyour profile. We respect your right to privacy. Viewour policy.
This email was sent by: Newsmax.com 362 N. Haverhill Road West Palm Beach, FL 33415 USA
Every day offers a new chance to grow—so explore stories filled with real-life inspiration, practical wisdom, and ideas that fuel your next step forward. Discover uplifting content curated to support your personal growth, and join thousands of readers who visit our site daily for motivation, insight, and a positive boost.
“Grace has a way of arriving quietly — not as a reward for perfection, but as a gift for simply showing up.”
Showing up — for the people you love, for the work you’ve been given, for yourself — is no small thing. It takes something real to keep choosing presence when life feels heavy. Give yourself credit for that today. And know that the grace you extend to others is also available to you. Receive it without hesitation.MORE INSPIRATION
You’re always one blessing away from a brighter day… and a bigger life. May these stories, affirmations, prayers, and insights lift your spirits and inspire you to lift others.
RJ Hamster 